Genotype distribution characteristics of multiple human papillomavirus in women from the Taihu River Basin, on the coast of eastern China.
There is limited data on the genotype distribution of human papillomavirus (HPV) in the Taihu River Basin, home to 1.29 million people on the coast of eastern China. This study evaluated the prevalence and genotypes among different female age groups in this region.



Twenty-six HPV strains (low-risk HPV 6, 11, 40, 42, 44, 61, 73 and high-risk HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 55, 56, 58, 59, 66, 68, 82, and 83) were detected using Tellgenplex™ HPV technology in samples obtained from three clinical hospitals located in different regions of the Taihu Lake Basin.



The results showed that 1855 samples (20.97% of all samples) were found to be HPV-positive. Of these, 1375 samples (15.55% of all samples) were found to have a single HPV infection. Age-specific prevalence showed two peaks, one that corresponded to the group of 21-30 year-old women and the other peak that corresponded to the group of women over 51 years old. The three most prevalent genotypes were HPV52 (19.95%, 370/1855), HPV16 (13.48%, 150/1855), and HPV58 (11.32%, 210/1855). Mixed strains HPV58 + HPV33 and HPV58 + HPV52 were most commonly found in females infected with multiple HPV types.



This investigation reveals that HPV infection in the Taihu River Basin varied significantly among different age groups. The most prevalent genotypes are included in the nonavalent vaccine, V503, however this vaccine is not licensed for use in mainland China. The most frequently occurring genotypes should be considered in the development of next-generation HPV vaccines for optimal protection of public health.
Department of Clinical laboratory, Wujiang First People's Hospital, Suzhou, People's Republic of China. petiteberyl@163.com.
Jing-Fen
JF
Lu
Department of Clinical laboratory, Wujiang First People's Hospital, Suzhou, People's Republic of China.
Guo-Rong
GR
Shen
Department of Clinical laboratory, Wujiang First People's Hospital, Suzhou, People's Republic of China.
Qiong
Q
Li
Department of Clinical laboratory, Wujiang First People's Hospital, Suzhou, People's Republic of China.
Xu
X
Chen
Department of Clinical laboratory, Wujiang First People's Hospital, Suzhou, People's Republic of China.
Chun-Fang
CF
Ma
Department of Clinical laboratory, Wujiang First People's Hospital, Suzhou, People's Republic of China.
Tong-Hua
TH
Zhu
D000328:Adult; D000368:Aged; D002681:China / Q000453:epidemiology; D004279:DNA, Viral / Q000032:analysis*; D005260:Female; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D027383:Papillomaviridae / Q000235:genetics* / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000821:virology*; D053918:Papillomavirus Vaccines; D015995:Prevalence; D012306:Risk; D045483:Rivers; D055815:Young Adult
D004279:DNA, Viral; D053918:Papillomavirus Vaccines
Cervical cancer; Distribution; Genotypes; Human papillomavirus